{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:26:49Z","timestamp":1784770009867,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20F20411"],"award-info":[{"award-number":["20F20411"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024796","name":"Nagai Foundation Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002385","name":"Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005623","name":"University of Tokushima","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xphs.2025.103882","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:37:49Z","timestamp":1750171069000},"page":"103882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using PEGylated antigen-expressing extracellular vesicles to accomplish splenic B cell-targeted antigen delivery for induction of antibodies against SARS-CoV-2 spike protein"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-8013","authenticated-orcid":false,"given":"Sherif E.","family":"Emam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7859-0280","authenticated-orcid":false,"given":"Nehal E.","family":"Elsadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-2239","authenticated-orcid":false,"given":"Haruka","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-7574","authenticated-orcid":false,"given":"Hidenori","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-6465","authenticated-orcid":false,"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.xphs.2025.103882_bib0001","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: from vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharmaceut Sin B"},{"issue":"14","key":"10.1016\/j.xphs.2025.103882_bib0002","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.xphs.2025.103882_bib0003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1248\/cpb.c22-00047","article-title":"Development of an antigen delivery system for a B cell-targeted vaccine as an alternative to dendritic cell-targeted vaccines","volume":"70","author":"Shimizu","year":"2022","journal-title":"Chem Pharmaceut Bull"},{"issue":"10","key":"10.1016\/j.xphs.2025.103882_bib0004","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.4049\/jimmunol.0804035","article-title":"Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles","volume":"182","author":"Keller","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J Controll Release"},{"issue":"3","key":"10.1016\/j.xphs.2025.103882_bib0006","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes1","volume":"292","author":"Dams","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0007","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(03)00085-1","article-title":"Accelerated clearance of a second injection of PEGylated liposomes in mice","volume":"255","author":"Ishida","year":"2003","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2025.103882_bib0008","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/acs.molpharmaceut.0c00366","article-title":"Impact of pre-existing or induced anti-PEG IgM on the pharmacokinetics of peginterferon alfa-2a (Pegasys) in mice","volume":"17","author":"Elsadek","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2025.103882_bib0009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2020.04.026","article-title":"Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice","volume":"152","author":"Elsadek","year":"2020","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"issue":"5","key":"10.1016\/j.xphs.2025.103882_bib0010","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.imbio.2012.08.274","article-title":"Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon","volume":"218","author":"Shimizu","year":"2013","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.xphs.2025.103882_bib0011","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.4049\/jimmunol.1701351","article-title":"A novel platform for cancer vaccines: antigen-selective delivery to splenic marginal zone B cells via repeated injections of PEGylated liposomes","volume":"201","author":"Shimizu","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.xphs.2025.103882_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.01.024","article-title":"A spleen-targeted vaccine for SARS-CoV-2 \u2014 Inducting neutralizing antibodies in mice","author":"Shimizu","year":"2025","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2025.103882_bib0013","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.vaccine.2021.01.008","article-title":"Lymphoid follicle antigen (Ag) delivery and enhanced rodent humoral immune responses mediated by Ag-containing PEGylated liposomes","volume":"39","author":"Shimizu","year":"2021","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.xphs.2025.103882_bib0014","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.xphs.2025.103882_bib0015","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1021\/acs.molpharmaceut.8b00277","article-title":"Exosomes as a drug delivery system in cancer therapy: potential and challenges","volume":"15","author":"Kibria","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2025.103882_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2022.02.020","article-title":"Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment","author":"Srivastava","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","article-title":"Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer","volume":"18","author":"Liang","year":"2020","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12951-019-0526-7","article-title":"Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy","volume":"17","author":"Gong","year":"2019","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0019","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jcp.30566","article-title":"Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer","volume":"237","author":"Hui","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.xphs.2025.103882_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejpb.2019.10.005","article-title":"Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues","volume":"145","author":"Emam","year":"2019","journal-title":"Eur J Pharmaceut Biopharmaceut"},{"key":"10.1016\/j.xphs.2025.103882_bib0021","series-title":"Liposomes: Methods and Protocols","first-page":"159","article-title":"The post-insertion method for the preparation of PEGylated liposomes","author":"Emam","year":"2023"},{"issue":"3","key":"10.1016\/j.xphs.2025.103882_bib0022","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J Controll Release"},{"issue":"3","key":"10.1016\/j.xphs.2025.103882_bib0023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0021-9258(18)70227-5","article-title":"Colorimetric assay methods for free and phosphorylated glyceric acids","volume":"234","author":"Bartlett","year":"1959","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.xphs.2025.103882_bib0024","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1248\/bpb.b17-00919","article-title":"A novel strategy to increase the yield of exosomes (extracellular vesicles) for an expansion of basic research","volume":"41","author":"Emam","year":"2018","journal-title":"Biol Pharmaceut Bull"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0025","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.24858","article-title":"The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling","volume":"3","author":"Van Deun","year":"2014","journal-title":"J Extracell Vesicl"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","article-title":"A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs","volume":"460","author":"Ishida","year":"1999","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.xphs.2025.103882_bib0027","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1021\/acs.bioconjchem.9b00587","article-title":"Copper-64 labeled PEGylated exosomes for In vivo positron emission tomography and enhanced tumor retention","volume":"30","author":"Shi","year":"2019","journal-title":"Bioconjug Chem"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0028","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1038\/s41598-021-84733-5","article-title":"Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma","volume":"11","author":"Maeda","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.xphs.2025.103882_bib0029","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41551-020-00660-2","article-title":"Neutralizing antibodies for the treatment of COVID-19","volume":"4","author":"Jiang","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"10.1016\/j.xphs.2025.103882_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109353","article-title":"Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects","volume":"36","author":"Jennewein","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.xphs.2025.103882_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105820","article-title":"Therapeutic antibodies and alternative formats against SARS-CoV-2","volume":"223","author":"Winiger","year":"2024","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduc Target Ther"},{"issue":"4","key":"10.1016\/j.xphs.2025.103882_bib0033","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.xphs.2025.103882_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110368","article-title":"A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection","volume":"38","author":"Beaudoin-Bussi\u00e8res","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-020-02622-3","article-title":"Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine","volume":"18","author":"Nikfarjam","year":"2020","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.xphs.2025.103882_bib0036","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41417-022-00427-8","article-title":"Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy","volume":"29","author":"Sohrabi","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.xphs.2025.103882_bib0037","series-title":"Diagnostic and Therapeutic Applications of Exosomes in Cancer","first-page":"161","article-title":"9 - diagnostic potential of tumor exosomes","author":"Hochendoner","year":"2018"},{"issue":"3","key":"10.1016\/j.xphs.2025.103882_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091463","article-title":"Dendritic cells pulsed with leukemia cell-derived exosomes more efficiently induce antileukemic immunities","volume":"9","author":"Yao","year":"2014","journal-title":"PLOS One"},{"issue":"11","key":"10.1016\/j.xphs.2025.103882_bib0039","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","article-title":"Induction of myeloid-derived suppressor cells by tumor exosomes","volume":"124","author":"Xiang","year":"2009","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.xphs.2025.103882_bib0040","first-page":"6636","article-title":"Dendritic cells loaded with HeLa-derived exosomes simulate an antitumor immune response","volume":"15","author":"Ren","year":"2018","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.xphs.2025.103882_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033330","article-title":"Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis","volume":"7","author":"Lee","year":"2012","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0042","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2345940","article-title":"Exosome may be the next generation of promising cell-free vaccines","volume":"20","author":"Dai","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0043","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1779991","article-title":"Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy","volume":"9","author":"Naseri","year":"2020","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.xphs.2025.103882_bib0044","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery. Review","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.xphs.2025.103882_bib0045","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10529-016-2185-1","article-title":"Exosomes derived from tumor cells genetically modified to express Mycobacterium tuberculosis antigen: a novel vaccine for cancer therapy","volume":"38","author":"Koyama","year":"2016","journal-title":"Biotechnol Lett"},{"issue":"33","key":"10.1016\/j.xphs.2025.103882_bib0046","doi-asserted-by":"crossref","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103882_bib0047","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/eji.1830130202","article-title":"Splenic B cells function as immunogenic antigen presenting cells for the induction of effector T cells","volume":"13","author":"Tzehoval","year":"1983","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.xphs.2025.103882_bib0048","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-021-03143-4","article-title":"Potential application of exosomes in vaccine development and delivery","author":"Huda","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103882_bib0049","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","article-title":"Biodistribution and delivery efficiency of unmodified tumor-derived exosomes","volume":"199","author":"Smyth","year":"2015","journal-title":"J Controll Release"},{"key":"10.1016\/j.xphs.2025.103882_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","article-title":"PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time","volume":"224","author":"Kooijmans","year":"2016","journal-title":"J Controll Release"},{"issue":"11","key":"10.1016\/j.xphs.2025.103882_bib0051","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/s41401-024-01327-3","article-title":"Lethal pulmonary thromboembolism in mice induced by intravenous human umbilical cord mesenchymal stem cell-derived large extracellular vesicles in a dose- and tissue factor-dependent manner","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.xphs.2025.103882_bib0052","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40824-023-00456-w","article-title":"Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery","volume":"27","author":"Jang","year":"2023","journal-title":"Biomater Res"},{"issue":"4","key":"10.1016\/j.xphs.2025.103882_bib0053","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492500334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492500334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:15:41Z","timestamp":1756404941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492500334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S002235492500334X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103882","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using PEGylated antigen-expressing extracellular vesicles to accomplish splenic B cell-targeted antigen delivery for induction of antibodies against SARS-CoV-2 spike protein","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103882"}}